Target
Programmed cell death 1 ligand 1
Ligand
BDBM649691
Substrate
n/a
Meas. Tech.
Affinity Test Between the Compounds of the Invention and hPD-L1 Protein
Kd
550±n/a nM
Citation
 XU, YZHANG, HZHU, QDU, HXIA, YYU, CHUANG, SLI, HZOU, Y NOVEL BIPHENYL DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF US Patent  US20240043392 Publication Date 2/8/2024 
Target
Name:
Programmed cell death 1 ligand 1
Synonyms:
B7 homolog 1 | B7-H1 | B7H1 | B7H1 | CD274 | CD_antigen=CD274 | PD-L1 | PD1L1_HUMAN | PDCD1 ligand 1 | PDCD1L1 | PDCD1LG1 | PDL1 | Programmed cell death 1 ligand 1 | Programmed death ligand 1
Type:
PROTEIN
Mol. Mass.:
33278.49
Organism:
Homo sapiens (Human)
Description:
ChEMBL_109807
Residue:
290
Sequence:
MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET
  
Inhibitor
Name:
BDBM649691
Synonyms:
(5-chloro-2-((5-cyanopyridin-3-yl)methoxy)-4-((3′-(3-(4-((((R)-1-methoxy-3-hydroxy-1-oxopropan-2-yl)amino)methyl)-1H-1,2,3-triazol-1-yl)propoxy)-2,2′-dimethyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)-D-serine | US20240043392, Compound II-19
Type:
Small organic molecule
Emp. Form.:
C42H46ClN7O9
Mol. Mass.:
828.309
SMILES:
COC(=O)[C@@H](CO)NCc1cn(CCCOc2cccc(c2C)-c2cccc(COc3cc(OCc4cncc(c4)C#N)c(CN[C@H](CO)C(O)=O)cc3Cl)c2C)nn1
Structure:
Search PDB for entries with ligand similarity: